No black box warning on record for Mefloquine Hydrochloride

As of the latest FDA labeling reviewed, Mefloquine Hydrochloride (MEFLOQUINE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Mefloquine Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS In case of life-threatening, serious or overwhelming malaria infections due to P. falciparum, patients should be treated with an intravenous antimalarial drug. Following completion of intravenous treatment, mefloquine may be given to complete the course of therapy. QTc Interval Prolongation and Drug Interactions Halofantrine should not be administered with mefloquine or within 15 weeks of

No black box warning on record for Mefloquine Hydrochloride

Other warnings & precautions

WARNINGS In case of life-threatening, serious or overwhelming malaria infections due to P. falciparum, patients should be treated with an intravenous antimalarial drug. Following completion of intravenous treatment, mefloquine may be given to complete the course of therapy. QTc Interval Prolongation and Drug Interactions Halofantrine should not be administered with mefloquine or within 15 weeks of

Mefloquine Hydrochloride Black Box Warning

No black box warning on record for Mefloquine Hydrochloride

Other warnings & precautions

Mefloquine Hydrochloride Black Box Warning

No black box warning on record for Mefloquine Hydrochloride

Other warnings & precautions